The Earlier You Know

Much of the "War on Cancer" money goes to curing the disease but in the latest issue of Wired, Thomas Goetz writes about the Canary Foundation, which is focused on early detection.  There, researchers are working on developing biomarker blood tests -- using proteomics to pinpoint proteins -- and new imaging tools. "A good biomarker will tell us something we don't know.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.